Agoracom Blog Home

Author Archive

Avicanna’s $AVCN.ca RHO Phyto™ Rapid Act Sprays are Now Available Nation Wide in Canada Through Medical Cannabis by Shoppers™ $WEED.ca $CL.ca $HEXO.ca

Posted by AGORACOM-JC at 9:27 AM on Monday, September 21st, 2020
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg

Avicanna Rapid Act Spray

  • RHO Phyto™ Rapid Act Sprays are now available nationwide in high ratios of CBD to THC and are designed for rapid absorption and with lemon-mint flavour on the Medical Cannabis by Shoppers™ portal.
  • The Rapid Act Sprays are also available for the Medical Cannabis Real World Evidence Studies (MC-RWE) conducted by the University Health Network in partnerships with Medical Cannabis by Shoppers along side RHO Phyto’s Micro Drop Oil formulations.

TORONTO , Sept. 21, 2020 – Avicanna Inc. (” Avicanna ” or the ” Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that its advanced RHO Phyto Rapid Act Sprays are now officially available nationwide in Canada on the Medical Cannabis by Shoppers (” Shoppers “) portal, as well as through the Medical Cannabis Real-World Evidence Study at the University Health Network.

Avicanna’s RHO Phyto product line is now commercially available after years of research and development through collaborations with world class academic and clinical organizations. The development of RHO Phyto products has focused on the key properties in drug development that health care providers seek when recommending a medical product to their patients such as formulation stability for consistent dosing, enhanced absorption and a range of onset times.

The Rapid Act Spray is a sublingual spray and is among the second set of Avicanna’s RHO Phyto products available for purchase through Shoppers. The sublingual sprays bypass first-pass metabolism and are quickly absorbed in the mucosal lining under the tongue. The RHO Phyto Rapid Act Spray provides an alternative delivery form to the RHO Phyto Micro Drops (also available for sale through Shoppers) which are absorbed through the oral route. The RHO Phyto Rapid Act Sprays have been formulated with specific ingredients that enhance absorption and the onset time of cannabinoids across the mucous membrane beneath the tongue. The lemon-mint flavoured sprays will be available in 10:20 CBD and 2:40 (w/w) THC to CBD ratios.

Dr. Justin Grant , Avicanna’s Executive Vice President of Scientific Affairs, commented, “The RHO Phyto Rapid Act Sprays are designed for faster onset and can be used in acute conditions where patients seek faster relief. The sublingual sprays can also be used to supplement slower and longer acting products, such as the RHO Phyto Micro Drop, when occasional higher doses may be required. Sublingual administration provides an alternative to the potentially harmful effects of consuming inhalation products.”

In August 2020 , Avicanna launched its blood orange flavoured RHO Phyto Micro Drop 2:50 CBD and Micro Drop 5:20 CBD. In the coming months, Avicanna will be launching its much-anticipated RHO Phyto Deep Tissue Gel, Daily Cream and Simple Dose Capsules. To ensure batch-to-batch consistency and high-quality products, these formulations are manufactured at MediPharm Labs Inc, a Good Manufacturing Practices (” GMP “) certified facility. In addition to strict GMP manufacturing, all RHO Phyto products undergo GMP-level analytical testing by Sigma Analytical Services Inc. and use blockchain technology developed by TruTrace Technologies Inc. to manage, track and trace each step of the supply chain.

Detailed guidelines outlining dosing and titration for Health Care Practitioners (” HCPs “) and patients is available on the RHO Phyto website at www.rhophyto.com . In addition, the Avicanna Academy includes additional product information for patients, frequently asked questions, and a recording of Avicanna’s 3rd annual symposium which was hosted virtually in partnership with Shoppers on July 21, 2020. For more information visit https://www.avicanna.com/the-avicanna-academy/ .

The Company has also re-branded and re-launched its subsidiary, My Cannabis Clinic (formerly known as My Cannabis), which specializes in assisting patients to gain access to medical cannabis and cannabinoid-based products for medical use. My Cannabis Clinic is devoted to providing HCPs and patients with the support and education needed for medical cannabis use. My Cannabis Clinic believes in providing quality care to patients and providing education on the considerations and potential benefits that cannabis has to offer for medical use. Information about My Cannabis Clinic can be found at https://mycannabisclinic.org/ .

About Avicanna

Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.

Avicanna is an established leader in cannabinoid research and development, which it primarily conducts at its R&D headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have developed and commercialized several industry leading product lines, including:

  • Pura H&W™: an advanced and clinically tested line of CBD consumer derma-cosmetic products; and,
  • RHO Phyto™: an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nation-wide across Canada in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart. RHO Phyto is the first strictly medical formulary of advanced “Cannabis 2.0” products, containing oils, sprays, capsules, creams, and gels, all developed with scientific rigour, manufactured under GMP standards and supported by pre-clinical data.

With ongoing clinical trials on its derma-cosmetic (Pura H&W), medical cannabis (RHO Phyto) and a pipeline of pharmaceutical products, Avicanna’s dedication to researching the important role that cannabinoids play in an increasingly wider scope of products has been at the core of the Company’s vision since its inception. Furthermore, Avicanna’s commitment to education is demonstrated through its annual medical symposium, the Avicanna Academy educational platform, and the My Cannabis Clinic patient program through its subsidiary company.

Avicanna manages its own supply chain including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia. Through these sustainable, economical, and industrial scale subsidiaries, Avicanna cultivates, processes, and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. Avicanna’s Avesta Genetica program specializes in the development and optimization of rare cultivars for commercial production along with feminized seeds for global export. In June 2020, Avicanna made history with a shipment of hemp seeds to the United States of America by completing the first ever export of hemp seeds from Colombia.

SOURCE Avicanna Inc.

Stay Connected

For more information about Avicanna, visit www.avicanna.com , call 1-647-243-5283, or contact Setu Purohit , President by email at [email protected] .

Cautionary Note Regarding Forward-Looking Information and Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and includes statements with respec t to the ability of the RHO Phyto Rapid Act Sprays to be used in acute conditions where patients seek faster relief, the ability of the RHO Phyto Rapid Act Sprays to be used to supplement slower and longer acting products, the ability of the Company launching the RHO Phyto Deep Tissue Gel, Daily Cream and Simple Dose Capsules , the ability of My Cannabis Clinic to provide HCPs and patients with the support and education needed for medical cannabis use, and that there is a benefit to using cannabis for medical purposes. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated April 15, 2020 , filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com .

The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Datametrex $DM.ca Receives Third COVID-19 Order from TV Production Company

Posted by AGORACOM-JC at 9:19 AM on Monday, September 21st, 2020
Webinar logo
  • Announced that it has received a third Purchase Order for COVID-19 screening solutions from Are You Afraid of the Dark Inc., a Canadian horror anthology television miniseries based in Vancouver, British Columbia.
  • The initial P.O. is for approximately $210,000 for a month, commencing on October 5, 2020
  • This production is scheduled to run for three (3) months, totalling $630,000.
  • Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits

Toronto, Ontario–(September 21, 2020) –  Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that it has received a third Purchase Order (“P.O.”) for COVID-19 screening solutions from Are You Afraid of the Dark Inc., a Canadian horror anthology television miniseries based in Vancouver, British Columbia.

The miniseries is produced by Nickelodeon Productions and distributed by MTV Networks in the United States and YTV in Canada, a Corus Entertainment company. Nickelodeon, now in its 41st year, is the number one entertainment brand for kids. Nickelodeon and all related titles, characters and logos are trademarks of Viacom Inc.

The initial P.O. is for approximately $210,000 for a month, commencing on October 5, 2020. This production is scheduled to run for three (3) months, totalling $630,000. Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits.

As previously stated, Vancouver is the third-largest production centre in North America, worth CDN $3.2 Billion during 2018/19, according to Creative BC. British Columbia is home to several world-class Film and TV studios, including Bridge Studios, Mammoth Studios, Vancouver Film Studios, North Shore Studios, Ironwood Studios, Canadian Motion Picture Park, and The Crossing Studios.

Entire film and TV production in Canada represent $8.92 Billion in production volume, and full-time equivalent jobs represent 179,000 workers. In March 2020, the industry stopped worldwide, including in Vancouver, which represents 37% of Canadian Productions. The surrounding areas of Vancouver had 46 productions filming, which does not include the TV commercial market. Each of the shows potentially had a minimum of 100 people in their film crew.1

The next largest film and television market is Ontario, which represents 34% of Canadian productions. In 2019, Toronto’s film and television industry directly employed more than 28,000 people representing $3.17 Billion in production volume.

Additionally, with Canada having far fewer cases of COVID-19 than in the United States on a per capita basis according to data compiled by Johns Hopkins University, it demonstrates that Canada is a safer jurisdiction for filming and an advocate for the film industry, with our testing kits, collection services and labs already set up.

“With Vancouver productions quickly returning to the studios and filming, we feel that this is the tip of the iceberg for new film business for COVID-19 screening business,” said Marshall Gunter, CEO of the Company.

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

MedX Health Corp. $MDX.ca Bolsters Global Footprint and Adds Renowned Skin Care Expert to Senior Leadership Team $DMTK $ICAD $PLSE $SRTS

Posted by AGORACOM-JC at 9:16 AM on Monday, September 21st, 2020
Home - MedX Health
  • Announced the appointment of veteran healthcare industry executive Naman Demaghlatrous as Managing Director, Europe, Middle East & Africa (“EMEA”), effective immediately
  • Additionally, Chantal Ward, RN has taken a permanent position with the Company as Director, Dermatological Services

MedX Health Corp. (“MedX”) (TSX-V: MDX) is pleased to announce the appointment of veteran healthcare industry executive Naman Demaghlatrous as Managing Director, Europe, Middle East & Africa (“EMEA”), effective immediately. Additionally, Chantal Ward, RN has taken a permanent position with the Company as Director, Dermatological Services.

“Naman’s extensive background in healthcare and medical devices, along with his deep relationships will allow us to accelerate business development opportunities in the region,” said Mike Druhan, President of Dermatological Products & Services. “Chantal is an internationally recognized and respected leader in the dermatology and aesthetics spaces, bringing credibility to our offerings and putting an impressive opinion leader network at our disposal.”

Mr. Demaghlatrous has more than 20 years of experience in the healthcare industry, including roles with medical device and pharmaceutical companies leading business strategy, international product licensing, business development and operations. He has proven expertise in leading organizations through start-up to rapid growth, expansion and value creation with companies such as Medtronic, Pediapharm, Johnson & Johnson and Atfal Pharma. Mr. Demaghlatrous will play an integral part in MedX’s revenue growth prospects by securing European, Middle Eastern and African partnerships for MedX’s skin assessment telemedicine technology. Initially supporting the roll out and expansions in the Netherlands, Spain and Turkey, he will also be responsible for securing joint ventures and partnerships across the EMEA Region.

“Helping patients access an e-consult on suspicious lesions or moles quickly and easily means better treatment and better outcomes,” noted Mr. Demaghlatrous. “There is already significant interest and traction across the region and I am expecting substantial growth over the next six to nine months.”

Chantal Ward RN, a Diploma Nurse Graduate from an operating room background, has 20+ years’ experience as a clinical trainer of advanced medical aesthetic equipment and technology. Her expertise is acknowledged across Canada and around the world, where she has provided guidance and training to hundreds of medical aesthetic professionals. Ms. Ward is Co-Founder of Clarity MedSpa & Laser Centre, Toronto and has significant experience with MedX’s SIAscopy on DermSecure™.

“I have been using this device in my clinic for several years and have caught multiple melanomas,” said Ms. Ward. “The device is easy to use and the ability to have a dermatologist provide a remote e-consult, within 72 hours, is critical. Early detection is the key to a successful patient outcome.”

“MedX is in full commercialization mode and Naman and Chantal are welcomed additions to our team. Recently, Damon Goodwin and Nick Hoffman have been announced to our senior management team and we are already feeling their impact. It is a satisfying to know that MedX can attract such seasoned professionals and I strongly believe that is because of the strength of our technology offering and the culture we have built,” further commented Mr. Druhan.

Currently, between two and three million non-melanoma skin cancers and 300,000 melanoma skin cancers occur globally each year. One in every three cancers diagnosed is a skin cancer and, according to Skin Cancer Foundation statistics, one in every five people will develop skin cancer in their lifetime. The global demand for SIAscopy on DermSecure™ will continue to increase with the growth of telemedicine and as early detection is recognized as the way to optimize survival and reduce healthcare costs.

About MedX

MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin health with its SIAscopy on DermSecure™ telemedicine platform, utilizing its SIAscopy™ technology. SIAscopy is also imbedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA, TGA and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union and Turkey. MedX also designs, manufactures and distributes quality photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. www.medxhealth.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This Media Release may contain forward-looking statements, which reflect the Company’s current expectations regarding future events. The forward-looking statements involve risks and uncertainties.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200921005178/en/

Contacts:

Mike Druhan, President, Dermatological Services
MedX Health Corp
Tel: 905-599-7852

Loop Insights $MTRX.ca Update Includes Wins With #TELUS, University Of Houston, $412,000 Government R&D Award And Imminent OTCQB Listing, With More Anticipated $QUIS.ca $MCLD.ca $NXO.ca

Posted by AGORACOM-JC at 9:11 AM on Monday, September 21st, 2020
Loop Insights – Medium
  • Company has been successful in reaching many milestones across both product lines, Contact Tracing, and Contactless Marketing, with world-renowned brands, which have led to accelerating opportunities and contract negotiations with potential customers of similar stature
  • Loop announced an exciting successful launch with Telus, Canada’s leading telecom company
  • Contact Tracing continues to be a huge focus and gaining traction throughout North America in several verticals
  • The company has expanded its contactless services and continues to engage in many large-scale opportunities throughout North America
  • company is pleased to announce that it has been awarded $412,000 from its 2019 Scientific Research & Experimental Development application

VANCOUVER, BC, Sept. 21, 2020 – Loop Insights Inc. (TSXV: MTRX) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, automated marketing, and contact tracing to the brick and mortar space, is pleased to provide shareholders with the following corporate update reviewing recent significant business wins and near term expectations.  The company has been successful in reaching many milestones across both product lines, Contact Tracing, and Contactless Marketing, with world-renowned brands, which have led to accelerating opportunities and contract negotiations with potential customers of similar stature.

BUSINESS DEVELOPMENT OPPORTUNITIES EXPANDING WITH EACH SUCCESSIVE WIN

Loop CEO Rob Anson stated “We have long known that our artificial intelligence driven technology stack could have a major impact on the real-world operations of enterprise-level customers, so it has been an incredible experience for Loop and its shareholders to begin seeing the third-party validation as we secure deals with great partners such as Telus, University of Houston and others. My message to shareholders is this is only the beginning, with Loop receiving significant inquiries, conducting online demonstrations and entering contract discussions on a daily basis.  Moreover,  we remain laser focused on maximizing our potential through  Tier-1 channel resellers to help us grow even faster. As such, I can say with great confidence that Loop is extremely well-positioned to anticipate a very strong and successful run for the remainder of 2020.

TELUS PARTNERSHIP IS INDICATIVE OF A GLOBAL DISTRIBUTION STRATEGY WITH NATIONAL TELECOM PROVIDERS

On September 17th,  Loop announced an exciting successful launch with Telus, Canada’s leading telecom company. This pilot program of our real-time, artificial intelligence-driven marketing platform launched in August and, upon successful completion, sees expansion into Telus 550+ corporate locations, as well as, their 2,000+ B2B reseller channel. This partnership is part of Loop’s global distribution strategy, in which the Company is already engaged in discussions with several similar telecom providers in the US, Australia, and other regions.

CONTACT TRACING ACCELERATES WITH INQUIRIES FROM GOVERNMENTS FOLLOWING PARTNERSHIP WITH NCAA DIV 1 UNIVERSITY OF HOUSTON

Contact Tracing continues to be a huge focus and gaining traction throughout North America in several verticals. The company has expanded its contactless services and continues to engage in many large-scale opportunities throughout North America. Areas of interest have come from, but not limited to, Provincial and Federal Government talks. Now that schools and sports teams are starting back up, contact tracing needs have never been as important. Securing University of Houston was a huge milestone and has now sparked interest throughout many other sports teams and schools across the US looking to restart and have a safe return of fans to their sporting facilities. Final negotiations are underway and the Company hopes to announce the next roll out in the near future.

LOOP RECEIVES  $412,000 FROM FEDERAL GOVERNMENT SR&D RESEARCH AND DEVELOPMENT PROGRAM

The company is pleased to announce that it has been awarded $412,000 from its 2019 Scientific Research & Experimental Development (“SR&ED”) application. In order to qualify for this program, Loop had to demonstrate it “generated information that advances the understanding of scientific relations or technologies or advances a certain technology or overcomes a technological uncertainty.”

This additional injection of funds further strengthens the company’s strong cash position, which positions the Company well for future M&A opportunities.

LOOP OTCQB APPLICATION IN FINAL STAGES IN RESPONSE TO US INVESTOR DEMAN

Over the past months, the Company has received increasing inquiries from US-based investors who could not easily acquire shares in Loop.  As a result, the company submitted applications to the necessary regulatory bodies and is hopeful for final approval as early as this week, making Loop shares available for trading on the OTCQB  with full DTC eligibility.

LOOP PARTNERSHIP WITH LEADING POS VENDOR (VEND) YIELDS IMMEDIATE RESULTS WITH NEW CUSTOMERS

Another major milestone was the partnership with Vend, a global point of sale supplier with over 25,000 locations in over 142 companies. Upon successful completion of the integration with Vend, Loop has already signed several Vend retailers including Your CBD Store, the largest CBD brick and mortar retailer in the United States with over 650 locations.

The Company is now in discussions on a distribution strategy with Vend’s leadership team to become a global reseller of the Loop products which will help accelerate Loop’s potential adoption throughout Vends global network of retailers.

As next steps in leveraging the success with Vend, the Company has also begun an integration roll out with one of the largest e-commerce platforms. Point of sale partners continues to be a large focus as they are the Company’s quickest path to scale while allowing the Company to remain lean and agile.

This Press Release Is Available On The Loop Insights Verified Forum On AGORACOM For Shareholder Discussion and Q&A https://agoracom.com/ir/LoopInsights/forums/discussion

About Loop Insights: Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia.

Forward-Looking Statements/Information: 

This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives. 

SOURCE LOOP Insights Inc.

For further information: Loop Insights Inc., Rob Anson, CEO, T: +1 877-754-5336 Ext. 4, E: [email protected], LOOP Website: www.loopinsights.ai, Facebook: @LoopInsights, Twitter: @LoopInsights, LinkedIn: @LoopInsights

Related Links

https://www.loopinsights.ai/

VIDEO – $HPQ.ca Silicon Development Agreement With #Apollon Solar Expands Into Producing HYDROGEN, With Samples To French Military By December $DUK $XEL $NEE $PYR.ca

Posted by AGORACOM-JC at 3:39 PM on Friday, September 18th, 2020

When a CEO puts this quote in a press release, you have to take it seriously, especially when his two technology partners helping deliver on it are world renowned:

“Since 2017, our collaboration with Apollon has enabled us to benefit from their world-renowned expertise with high value-added Silicon applications.  The addition of manufacturing hydrogen by hydrolysis to our collaboration opens up a new and unique business opportunity that could represent a second multibillion-dollar addressable market for the PUREVAPTM Nano Silicon (Si) Reactor (“NSiR”) nanopowders.

HYDROGEN BY HYDROLYSIS

Two technologies that could deliver vehicles with zero emissions are battery-electric powertrains and hydrogen fuel cells. HPQ is already on the road to becoming an electric battery player, with 2 NDA’s signed in the space – and now will be ready to start sending samples of its nano silicon powders to manufacture Hydrogen by hydrolysis, which is: 

“Getting porous silicon nano powders to react with water “H2O” and thereby releasing significant quantities of Hydrogen ” H2  “.

For decades, hydrogen was presumed to be “the fuel of the future,” with electric cars limited to the niche of small, short-range urban cars – but hasn’t been able to deliver due to too many issues to mention here with fuel cells.  Hydrogen by Hydrolysis is a great alternative but cost prohibitive due to the costs of porous silicon nano powders + power generation inefficiencies …. until now.

Enter HPQ Silicon.  

HPQ Silicon is so confident it can solve this problem that it will have samples of its powders ready for delivery to Apollon Solar and the French Military for testing by December.

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

VIDEO – Loop Insights $MTRX.ca Continues Contactless Dominance With Telus Agreement + University Of Houston Back To Back $QUIS.ca $MCLD.ca $NXO.ca

Posted by AGORACOM-JC at 9:49 PM on Thursday, September 17th, 2020
Loop Insights – Medium

Sometimes you just have to let the facts speak for themselves. Telus is one of Canada’s largest telecom companies with over 9,000,000 subscribers and a market capitalization of $30,000,000,000 (BILLION) … and they had this to say about Loop Insights (MTRX:TSXV)

Andrew Turner, VP Strategic Operations at TELUS TELUS sees great value in Loop’s real-time data connectivity applications across bricks and mortar retail environments. Known for consistently putting our customers first and driving innovation in the telecommunications industry, we are always looking to elevate our customer experience and provide our customers with more value. We look forward to seeing Loop in action, and learning how we can enhance the customer experience together.”

We don’t know if there is anything more to be said, with MTRX trading over 6,000,000 shares in just 4 hours today – but we will say this for everyone who is new to MTRX, who we’ve been pounding the table on for the last 3 months.

MTRX is one amazing CONTACTLESS technology company who was on its way to great success prior to COIVD-19 and has now risen to super relevancy across North America with 2 powerful applications (and revenue streams):

1.  Contact Tracing – The process of identification of persons who may have come into contact with an infected person, leading to subsequent collection of further information about these contacts 

  • Implemented By University Of Houston Yesterday (September 16, 2020)\
  • Implemented Into the Las Vegas flagship properties of a Global Hospitality company (July 23, 2020)
  • Invited by NCAA DIV 1 BIG EAST CONFERENCE To Present Solution For 11 schools (August 17, 2020)
  • Partnership with BDG sports to deliver NBA, NHL, NCAA and PGA Sporting Events. (August 13, 2020)

2.  Artificial Intelligence Marketing Solutions – To provide personalized promotions and targeted engagement for the bricks and mortar space

If you are looking at all the size and dates of these announcements and noticing a trend, you should be.  Loop Insights is starting to make some very serious inroads with some of the biggest organizations on the continent …. and it’s only September 17th.  

Watch this incredible interview with MTRX CEO, Rob Anson and hear what else he has to say about where Loop Insights is going.

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

CLIENT FEATURE: Else Nutrition $BABY.ca The Award Winning, Plant-Based Nutrition Company For Small Cap Investors $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 5:54 PM on Thursday, September 17th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

(TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL)

A Game Changer In Plant-Based Nutrition

Highlights

  • $CAD 18M bought deal financing + $CAD 6M private placement
  • US distribution agreement signed
  • Full-scale marketing campaign launched
  • Backed by A Billion Dollar Global Nutrition Company;
  • “Best Health” Award At Global Food Innovation Summit In Milan;
  • Awarded Patents In 22 Countries, 44 Countries Pending;
  • USDA Organic Certification and multiple other key certifications.
  • Partnership with celebrity author, podcast host and parenting expert, Hilaria Baldwin

Why Else Nutrition?

  • Gives Small Cap Investors An Opportunity To Participate In Global Paradigm Shift Towards Plant-Based, Clean Label Foods For Toddlers & Children
  • 7 Years of  R&D
  • Launched 1st Commercial Product Into US Market
  • 100% Plant-Based, Organic Toddler Nutrition Product 
  • Market Research Survey Finds Over 60% Positive Purchase Intent For Else Product
  • Fills A Market Gap In Plant-Based Toddler Nutrition (12-36 months)
  • Subsidiary Of Billion Dollar Hong Kong Listed Conglomerate (H&H) Owns Approx 11.15% Of BABY
  • H&H Right To Maintain 11.15% Ownership Through Future Financings

Watch Out Alec Baldwin, Hilaria’s Got a New Love 😉

https://youtube.com/watch?v=UBiYSt9Jekg

The Product

Else Plant-Based Toddler Nutrition

Dairy-free | Soy-free | Corn Syrup-free | Gluten-free

Hub On AGORACOM / Corporate Profile

Else Nutrition Holdings is an advertising client of AGORA Internet Relations Corp.

$HPQ.ca and Apollon Solar Extend Agreement to Work on Porous Silicon for Batteries and Expand Collaboration to Include Hydrogen Production $DUK $XEL $NEE $PYR.ca

Posted by AGORACOM-JC at 1:04 PM on Thursday, September 17th, 2020
  • Announced the extension, until December 31, 2020, of the Development Agreement signed with Apollon solar SAS in 2017
  • This fifth renewal will be focused on extremely promising venues for both the renewable energy sector and the decarbonization of the economy

MONTREAL, Sept. 17, 2020 — HPQ Silicon Resources Inc. (“HPQ” or “ Company”) TSX-V: HPQ; FWB: UGEOther OTC : URAGF; is pleased to announce the extension, until December 31, 2020, of the Development Agreement signed with Apollon solar SAS (“Apollon”) in 2017.  This fifth renewal will be focused on extremely promising venues for both the renewable energy sector and the decarbonization of the economy, mainly:

  1. Energy Storage development of a new generation of Lithium-ion batteries made using Porous Silicon manufactured by the transformation of HPQ PUREVAPTM Quartz Reduction Reactor “QRR” Silicon (Si) with Apollon patented process;

  2. Clean Renewable Hydrogen Production using Apollon Solar Gennao H2TM  200W, a fuel cell – based system that can produce hydrogen by hydrolysis simply by combining water with an environmentally friendly1 chemical powder.  Replacing the chemical powder presently used with nano silicon powders, such as those about to be produced by the HPQ NANO PUREVAPTM Nano Silicon Reactor (“NSiR”), could significantly increase the hydrogen generation capacity of the system.

“Since 2015, HPQ has been working on revolutionizing silicon manufacturing and its applications with the development of our PUREVAPTM technologies, scalable and extremely versatile processes that will allow the production of silicon materials perfectly suited to assist in the goals of decarbonization of the economy and the generation of green renewable energies” said Bernard Tourillon, President & CEO of HPQ Silicon Resources Inc.  “Since 2017, our collaboration with Apollon has enabled us to benefit from their world-renowned expertise with high value-added Silicon applications.  The addition of manufacturing hydrogen by hydrolysis to our collaboration opens up a new and unique business opportunity that could represent a second multibillion-dollar addressable market for the PUREVAPTM Nano Silicon (Si) Reactor (“NSiR”) nanopowders.”

APOLLON PROCESS: MAKING POROUS SILICON MANUFACTURING ECONOMICALLY VIABLE

Porous silicon is a Silicon (Si) structure in which Nanopores have been formed by electrochemical etching.  Addressable markets for porous silicon are substantial, but existing electrochemical etching processes require very pure Silicon (Si) feed stock (9N to 11N), making porous Silicon cost prohibitive.

To make affordable porous Silicon, Apollon developed and obtained a worldwide patent for an electrochemical etching process that can use (2N to 4N) Silicon (Si) to make porous Silicon wafers.

AIMING TO SEND POROUS SILICON NANOPOWDER SAMPLES TO END USERS BY DECEMBER 2020

Mindful of HPQ’s competitive advantage, the ability of PUREVAPTM QRR to produce 2N to 4N Silicon (Si) at the lowest cost in the industry, HPQ and Apollon are busy manufacturing samples of porous Si nanopowders of different sizes (2 nm to 1 µm) with porous structure sizes of either Microporous (<5nm), Mesoporous (5nm – 50nm) and Macroporous (>50nm).  The aim being to send samples, to end users’ specifications, by December 2020.  The extension of the agreement continues HPQ’s North American exclusivity over the use of Apollon’s patented process to manufacture Porous Silicon until at least December 31, 2020.

________________
1 Non-toxic and recyclable

HYDROLYSIS HYDROGEN PRODUCTION: APOLLON SOLAR’S GENNAO H2TM SYSTEM

Apollon Solar is also active in hydrogen based clean renewable energy.  Over the years, they have developed an expertise in hydrogen production by hydrolysis, getting porous silicon nano powders to react with water “H2O” and therewith releasing significant quantities of hydrogen “H2”.

Drawing on this unique expertise, Apollon was approached by the French government to develop a compact and portable hydrogen-based electricity generation system that must be reliable and efficient enough to charge military personnel batteries on missions.  This work led to the creation of the Gennao H2TM a self-contained system that integrates a fuel cell.  The system operation is simple; a chemical powder is introduced, and as the powder reacts with water, hydrogen is generated by hydrolysis and converted into electricity by the integrated fuel cell, thus allowing the system to charge several batteries at once.

The operational capabilities of the system having reached the validation phase of the French military program, Apollon Solar is now ready to start the commercialization of a civilian version of its GennaoTM H2 system.

COLLABORATION WITH HPQ SILICON TO CREATE MORE EFFICIENT AND ECONOMICAL HYDROGEN

With Apollon Solar’s Hydrogen business having entered the commercial phase, HPQ took advantage of the 5th renewal to include it in the scope of the agreement.

Even though using porous silicon nanopowders would double the amount of hydrogen released by the system, the high costs of making porous silicon nanopowders required Apollon to use a less efficient, but more economical and environmentally friendly chemical powder to launch its GennaoTM H2 system.

With a goal of increasing the efficiency of the system, HPQ and Apollon will explore the technical and commercial potential of creating a new generation of more efficient, economical and environmentally friendly powders for the GennaoTM system using either:

  1. Silicon nanopowders made by HPQ’s PUREVAPTM Nano Silicon Reactor to increase the H2 generation potential of the GennaoTM H2 system by 40% (based on the mass capacity production of H2 of 14% of Silicon Nanopowders);
       a. By December 2020, HPQ-NANO plans to send Apollon the first samples of silicon nanopowders manufactured by PUREVAPTM NSiR for H2 generation testing;

  2. Porous silicon nanopowders manufactured with the transformation of Silicon produced by HPQ’s PUREVAPTM QRR process in Apollon’s patented process, to increase the H2 generation potential of the GennaoTM H2 system by 100% (based on the mass capacity production of H2 of 20% of Silicon Nanopowders);

Also included in the agreement is the right for HPQ to commercialize, exclusively in Canada, and non-exclusive in the U.S.A., the GennaoTM H2 system, as well as, also distribute and sell the powders required for the hydrolysis production of Hydrogen (“H2”).

Apollon will support HPQ North American marketing of the GennaoTM H2 system and the powder bags.  By November 2020, Apollon will make available to HPQ a GennaoTM H2 system and the bags of powder needed for demonstration to potential buyers.

During the term of this fifth renewal, Apollon and HPQ will work to finalize a long-term commercial agreement that will grant HPQ (or one of its subsidiaries) a Canadian exclusivity for the sale of GennaoTM H2 system and associated powders bags, and the exclusivity for all customers located in the United States to whom HPQ is marketing GennaoTM H2 system.

Finally, the parties have agreed that during the renewal period, or until the date of the signing of a long-term commercial agreement, that HPQ will have Canadian exclusivity on the distribution, sale, marketing and representation of GennaoTM H2 system and associated powders, and that it will be able to distribute, sell, market and represent GennaoTM H2 system and associated powders with customers in the United States.

About Silicon

Silicon (Si), also known as silicon metal, is one of today’s strategic materials needed to fulfil the Renewable Energy Revolution (“RER”) and the decarbonization of the economy presently under way.  Silicon does not exist in its pure state; it must be extracted from quartz (SiO2), in what has historically been a capital and energy intensive process.

About HPQ Silicon

HPQ Silicon Resources Inc. (TSX-V: HPQ) is a Canadian producer of Innovative Silicon Solutions, based in Montreal,  building a portfolio of unique high value specialty silicon products needed for the coming RER.

Working with PyroGenesis Canada Inc. (TSX-V: PYR), a high-tech company that designs, develops, manufactures and commercializes plasma – based processes, HPQ is developing:

  • The PUREVAPTM “Quartz Reduction Reactors” (QRR), an innovative process (patent pending), which will permit the one step transformation of quartz (SiO2) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential;

    — HPQ believes it will become the lowest cost (Capex and Opex) producer of silicon (Si) and high purity silicon metal (3N – 4N Si);

  • The PUREVAPTM Nano Silicon Reactor (NSiR), a new proprietary process that can use different purities of silicon (Si) as feedstock, to make spherical silicon nanopowders and nanowires;

    — HPQ believes it can also become the lowest cost manufacturer of spherical Si nanopowders and silicon-based composites needed by manufacturers of next-generation lithium-ion batteries;

    — During the coming months, spherical Si nanopowders and nanowires silicon-based composite samples requested by industry participants and research institutions’ will be produced using PUREVAPTM SiNR.

HPQ is also working with industry leader Apollon Solar of France to:

  • Use their patented process and develop a capability to produce commercially porous silicon (Si) wafers and porous silicon (Si) powders;

    — The collaboration will allow HPQ to become the lowest cost producer of porous silicon wafers for all-solid -state batteries and porous silicon powders for Li-ion batteries;

    — Develop the hydrogen generation potential of Silicon nanopowders for usage with the GennaoTM system;

    — Commercialize, exclusively in Canada, and non-exclusive in the U.S.A., the GennaoTM H2 system and the chemical powders required for the hydrolysis production of Hydrogen (“H2”).

This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders. 

Disclaimers:

The Corporation’s interest in developing the PUREVAP™ QRR and any projected capital or operating cost savings associated with its development should not be construed as being related to the establishing the economic viability or technical feasibility of any of the Company’s Quartz Projects.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact

Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011
Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239
http://www.hpqsilicon.com Email: [email protected]

Augmented Reality #AR and Virtual Reality #VR in Sports and Entertainment Market Will Reflect Significant Growth – SPONSOR: Imagine AR $IP.ca $IPNFF $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 12:28 PM on Thursday, September 17th, 2020

SPONSOR: Imagine AR Inc. (IP:CSE) (IPNFF:OTCQB) is an Augmented Reality platform that allows businesses to easily launch AR campaigns. Clients Include: NBA Sacramento Kings, Mall of America, AT&T Shape and The Basketball Hall of Fame. The company announced partnership with Engaged Nation, an award winning leader in digital engagement marketing for casinos in addition to a collaboration with Music Superstar Flo Rida. The company also signed of a five year $250,000USD licensing agreement with WaV Sports & Entertainment for the launch of their new proprietary line of global sports engagement products. Learn More.

http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

Augmented Reality and Virtual Reality in Sports and Entertainment Market Forecast to 2027 – Covid-19 Impact and Global Analysis

  • AR and VR are the technologies which immerse the user into virtual world and allows to interact with the virtual objects being in real environment
  • The new interface of communication offered by AR and VR technology will overtake the markets of existing interfaces in the gaming and entertainment activities

By:tip September 15, 2020

“Augmented Reality and Virtual Reality in Sports and Entertainment Market” study by “The Insight Partners” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.

Smart phones are the must have digital devices today, they have changed the way we communicate, travel, design, run business and many more. In recent years smartphones revolutionized the world and still the ongoing R&Ds to launch advanced features, improved and more customer centric and enterprise level applications holds the market for years to go. AR and VR are the technologies which immerse the user into virtual world and allows to interact with the virtual objects being in real environment. The new interface of communication offered by AR and VR technology will overtake the markets of existing interfaces in the gaming and entertainment activities.

The global augmented reality and virtual reality in sports and entertainment market is segmented on the basis of software type and device. Based on software type, the augmented reality and virtual reality in sports and entertainment market is segmented into augmented reality software and virtual reality content creation. The augmented reality and virtual reality in sports and entertainment market on the basis of the device is classified into augmented reality head-mounted device and virtual reality head-mounted device. The report “Augmented Reality and Virtual Reality in Sports and Entertainment Market” gives varied description about the segmentation of the market on the basis of segmented software type, device and geography. And leads with a descriptive structure of the trends and restrictions of the various segments and sub segments. It also provides the market size and estimates a forecast from the year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The report also provides exhaustive PEST analysis for all five regions after evaluating political, economic, social and technological factors effecting the Typhoid Vaccines market.

Smartphone and tablets manufacturers are integrating more AR applications to increase the user experience and with growing smartphone market, AR integrations are expected to take a leap in near future which is anticipated to be the major driver for the augmented reality and virtual reality in sports and entertainment market. Lack of technological understanding and awareness about these products coupled with higher costs associated would pose a challenge to the growth of the augmented reality and virtual reality in sports and entertainment market. Huge investments towards technological advancements in the sports and entertainment sector would provide good opportunities to the players operating in the augmented reality and virtual reality in sports and entertainment market.

Source: https://www.kws24.com/augmented-reality-and-virtual-reality-in-sports-and-entertainment-market-will-reflect-significant-growth-in-future-artoolworks-blippar-eon-reality-google-htc-corporation-microsoft/

Esports Entertainment Group $GMBL Generates 400% Growth in New Registered Users During VIE.gg CS:GO Legend Series Tournament $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

Posted by AGORACOM-JC at 8:14 AM on Thursday, September 17th, 2020
  • VIE.gg CS:GO Legend Series Reaches Record 1.7 Million Unique Viewers
  • Tournament Now the Most-Watched Legend Series Event in Allied Esports History
  • New registered users grew 400% and customer deposits increased 300% during the two-week period of the VIE.gg CS:GO Legend Series Tournament compared to the same two weeks in the prior month

BIRKIRKARA, Malta, Sept. 17, 2020 — Esports Entertainment Group, Inc. (NasdaqCM: GMBL, GMBLW) (or the “Company”), a licensed online gambling company with a focus on esports wagering and 18+ gaming, today announced new registered users grew 400% and customer deposits increased 300% during the two-week period of the VIE.gg CS:GO Legend Series Tournament compared to the same two weeks in the prior month.

The Company’s partner, Allied Esports, a global esports entertainment company and a subsidiary of Allied Esports Entertainment, Inc. (NASDAQ: AESE), drew 1.7 million unique viewers for the VIE.gg CS:GO Legend Series tournament, which ended Sunday, September 13. The two-week competition, which also generated over 1 million hours watched and reached 98,000 peak viewers, is the most-watched Legend Series event since the tournament series was created in 2017.

“We are absolutely thrilled with the viewership numbers for the VIE.gg CS:GO Legend Series, a new benchmark for Allied Esports and a great introduction of our VIE.gg brand to fans around the world,” commented Grant Johnson, CEO of Esports Entertainment Group. “With a 400% increase in new users and 300% increase in deposits, we’ve clearly demonstrated there is demand for our platform. This was a great start to our marketing efforts, and we’re excited to pursue similar opportunities moving forward.”

Each broadcast during the VIE.gg CS:GO Legend Series tournament prominently featured a wagering component, including dynamic live odds that were on display for the entirety of each match. 

“This tournament was an excellent start to our partnership with Esports Entertainment Group, as we introduced their wagering platform to millions of people around the world, and we look forward to creating more valuable content with them in the near future,” said Frank Ng, CEO of Allied Esports Entertainment. “The VIE.gg CS:GO Legend Series is a great example of the ability of our tournaments to deliver dedicated content to an enthusiastic, engaged audience, and we will continue to develop these brands to meet the needs of partners as the esports industry continues to evolve.”

The professional Counter-Strike tournament, which was produced from Allied Esports’ HyperX Esports Studio in Hamburg, Germany, was a global event reaching esports audiences across multiple continents and languages. Allied Esports worked with various partners to broadcast the tournament on Twitch in six languages – English, Portuguese, Russian, Spanish, French and German – and on Chinese streaming platform HUYA, which carried both English and Chinese streams.

The VIE.gg CS:GO Legend Series featured 16 Counter-Strike teams from multiple European countries, the Commonwealth of Independent States (CIS) region and South America, including seven teams ranked in the top 50 globally. Kazakhstan’s Winstrike, which jumped from No. 60 in the world at the start of the tournament to No. 34, defeated 32nd-ranked Heretics from France 3-0 in the best-of-five Grand Final to secure the first VIE.gg CS:GO Legend Series title and €17,000 of the €50,000 total prize pool. Every game from the two-week tournament can be watched in full at youtube.com/alliedesports.

“We are very happy with the results of our first esports tournament sponsorship and the strong uptick in new sign ups and deposits we saw as a result of reaching millions of fans globally,” added Magnus Leppäniemi, Vice President of Marketing and Head of Esports at Vie.gg. “The VIE.gg CS:GO Legend Series provided a great opportunity to support tier 2 and tier 3 teams, a large and important segment of the esports community, and we look forward to continuing our support of these teams in the future.”

The VIE.gg CS:GO Legend Series was Allied Esports’ seventh edition of the CS:GO Legend Series and the 13th Legend Series event overall and part of its efforts to expand the competitive ecosystem and total prize pool for teams ranked outside of the first tier.

ABOUT ESPORTS ENTERTAINMENT GROUP

Esports Entertainment Group, Inc. is a licensed online gambling company with a specific focus on esports wagering and 18+ gaming. Esports Entertainment offers fixed odds wagering, fantasy and pools on various esports events in a licensed, regulated and secure platform at vie.gg and owns and operates online sports book, SportNation.bet. In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multiplayer mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and the video game industries, and esports. The Company holds a license to conduct online gambling and 18+ gaming on a global basis in the UK, Ireland, Malta and Curacao. The Company maintains offices in New Jersey, the UK and Malta. For more information visit www.esportsentertainmentgroup.com.

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Contact:

U.S. Investor Relations 
RedChip Companies, Inc.
Dave Gentry
407-491-4498
[email protected]

Media & Investor Relations Inquiries
[email protected]